nano, with all due respect, no matter how promising, they haven't even announced the results in mice, let alone primates or humans. There may be FDA shortcuts due to impending need but given that only 10% or so of new drugs/vacines survive clearance, I think there is substantial risk that these private investors will be unwilling to take at today's market price of $2. We all agree this is a novel technology.